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Abstract 
Detecting  epistatic  (nolinear)  interactions  among 
single nucleotide polymorphisms (SNPs) at multiple 
loci is important in the analysis of genomic data in 
association  studies.  We  developed  a  Bayesian 
combinatorial partitioning (BCP) for detecting such 
interactions  among  SNPs  that  are  predictive  of 
disease.  When  compared  with  multifactor 
dimensionality  reduction  (MDR),  a  widely  used 
combinatorial  partitioning  method  for  detecting 
interactions,  BCP  has  significantly  greater  power 
and is computationally more efficient. 
Background 
The  development  of  high-throughput  genotyping 
technologies to simultaneously assay many thousands 
of single nucleotide polymorphisms (SNPs) has led to 
a flurry of studies with the aim of uncovering SNPs 
associated with common diseases. Such studies have 
uncovered more than 50 common variants that have 
been found to be associated with disease such as type 
2  diabetes,  cardiac  and  immunological  diseases.  In 
addition,  interactions  among  genetic  variants  at 
multiple loci are likely to play an important role in 
such  diseases,  and  an  important  challenge  in  the 
analysis of SNP data is the identification of epistatic 
loci  that  interact  in  a  nonlinear  fashion  in  their 
association with disease. Biologically, epistasis refers 
to gene-gene interaction when the action of one gene 
is  modified  by  one  or  several  other  genes. 
Statistically,  epistasis  refers  to  interaction  between 
genetic  variants  at  multiple  loci  in  which  the  net 
effect on disease from the combination of genotypes 
at the different loci is not accurately predicted by a 
simple linear combination of the individual genotype 
effects. The detection of statistical epistasis has the 
potential  to  identify  interacting  genetic  loci  that 
interact biologically. 
Methods for detecting epistasis 
While  traditional  statistical  methods  like  logistic 
regression  can  identify  interactions,  it  is  unable  to 
identify interactions among SNPs that do not possess 
significant univariate effects. For identifying epistatic 
interactions  that  may  not be detected by traditional 
methods,  data  mining  techniques  such  as  set 
association  analysis,  genetic  programming,  neural 
networks, random forests and combinatorial methods 
have  been  applied  [1].  In  particular,  combinatorial 
methods search over all possible combinations of loci 
to find combinations that are predictive of disease. A 
widely used combinatorial partitioning method is the 
multifactor dimensionality reduction method (MDR) 
that  has  been  successfully  applied  in  identifying 
epistatic  interactions  in  several  diseases  [2].  MDR 
exhaustively evaluates single SNPs, 2-SNPs, 3-SNPs, 
up  to  n-SNPs  in  their  ability  to  accurately  predict 
disease  by  using  cross-fold  validation.  We  have 
developed  a  novel  combinatorial  method  called 
Bayesian combinatorial partitioning (BCP) that uses a 
Bayesian score to evaluate single SNPs, 2-SNPs, 3-
SNPs, up to n-SNPs in their ability to predict disease. 
Evaluation 
We evaluated BCP and MDR on a synthetic dataset 
for  combinations  of  up  to  4-SNPs.  BCP  had 
significantly  greater  power  (i.e.,  higher  accuracy  in 
correctly identifying interacting SNPs) and was 50-
140  times  faster  than  MDR.  This  is  likely  due  to 
BCP’s ability to use the entire dataset for evaluating a 
combination  compared  to  MDR  which  performs 
cross-fold validation to evaluate a combination.  
Even though BCP is substantially faster than MDR, 
exhaustive evaluation of all combinations is infeasible 
for high dimensional datasets like those generated in 
genome-wide association studies. In future work we 
plan  to  develop  heuristics  to  reduce  the number of 
combinations that will have to be evaluated. 
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